NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025
Shaji Kumar, Natalie S. Callander, Kehinde Adekola, Larry Anderson, Muhamed Baljević, Rachid Baz, Erica Campagnaro, Caitlin Costello, Christopher R. D’Angelo, Benjamin A. Derman, Srinivas Devarakonda, Noura Elsedawy, Amandeep Godara, Kelly Godby, Jens Hillengaß, Leona Holmberg, Myo Htut, Carol Ann Huff, Malin Hultcrantz, Yubin Kang, Sarah Larson, Hans C. Lee, Michaela Liedtke, Thomas G. Martin, James Omel, Timothy Robinson, Aaron S. Rosenberg, Mark A. Schroeder, Daniel W. Sherbenou, Attaya Suvannasankha, Jason Valent, Asya Varshavsky‐Yanovsky, Dan T. Vogl, E Kovách, Rashmi Kumar
Abstract
The NCCN Guidelines for Multiple Myeloma (MM) provide recommendations for diagnosis, initial workup, treatment, follow-up, and supportive care for patients with MM. These NCCN Guidelines Insights highlight the important updates and changes specific to systemic therapy for patients with newly diagnosed as well as previously treated MM included in Version 1.2025 of the NCCN Guidelines for MM.